Evidence mapPaperPMID 35757347Full record

ArticleFrontiers in cardiovascular medicine2022

Pre-transplant Type 2 Diabetes Mellitus Is Associated With Higher Graft Failure and Increased 5-Year Mortality After Heart Transplantation.

Rasmus Rivinius, Carolin Gralla, Matthias Helmschrott, Fabrice F Darche, Philipp Ehlermann, Tom Bruckner, Wiebke Sommer, Gregor Warnecke, Stefan Kopf, Julia Szendroedi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients with Diabetes Mellitus Following Heart Transplantation: A Meta-analysis.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Who is the Candidate? The Heart Transplant Evaluation Process.Methodist DeBakey cardiovascular journal · 2025
    Review
  10. Empagliflozin Use in Cardiac Transplant Patients:Sultan Qaboos University medical journal · 2025
    Article
  11. Article
  12. Article
  13. Heart Transplantation.Journal of clinical medicine · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Rasmus RiviniusDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Carolin GrallaDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Matthias HelmschrottDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Fabrice F DarcheDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Philipp EhlermannDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Tom BrucknerInstitute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
Wiebke SommerDepartment of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Gregor WarneckeDepartment of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Stefan KopfDepartment of Internal Medicine I and Clinical Chemistry, Heidelberg University Hospital, Heidelberg, Germany.
Julia SzendroediDepartment of Internal Medicine I and Clinical Chemistry, Heidelberg University Hospital, Heidelberg, Germany.
Norbert FreyDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Lars P KihmDepartment of Internal Medicine I and Clinical Chemistry, Heidelberg University Hospital, Heidelberg, Germany.
Heidelberg University · DEHeinrich Heine University Düsseldorf · DEDeutsches Diabetes-Zentrum e.V. · DEUniversity Hospital Heidelberg · DEZimmer Biomet (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Cardiac transplant recipients often suffer from type 2 diabetes mellitus (T2DM) but its influence on graft failure and post-transplant mortality remains unknown. The aim of this study was to investigate the long-term effects of pre-transplant T2DM in patients after heart transplantation (HTX). Methods: This study included a total of 376 adult patients who received HTX at Heidelberg Heart Center between 01/01/2000 and 01/10/2016. HTX recipients were stratified by diagnosis of T2DM at the time of HTX. Patients with T2DM were further subdivided by hemoglobin A1c (HbA1c ≥ 7.0%). Analysis included donor and recipient data, immunosuppressive drugs, concomitant medications, post-transplant mortality, and causes of death. Five-year post-transplant mortality was further assessed by multivariate analysis (Cox regression) and Kaplan-Meier estimator. Results: About one-third of all HTX recipients had T2DM (121 of 376 [32.2%]). Patients with T2DM showed an increased 5-year post-transplant mortality (41.3% versus 29.8%; Conclusion: Pre-transplant T2DM is associated with higher graft failure and increased 5-year mortality after HTX.

Indexed as

diabetes mellitusgraft failureHbA1cheart transplantationmortalitysurvival

Identifiers

PMID35757347
PMCPMC9218221
OpenAlexW4281661175

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.